Therapeutic Asset Ratings
622 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-OH (LS301)
Breast Cancer
Integro Theranostics
P1/2
CC
(42)
e-602
Breast Cancer
Palleon Pharmaceuticals, Inc.
P1/2
CC
(42)
H-gamma1 heavy chain Homo sapiens (1-447) [VH (Homo sapiens IGHV4-59*01 (99.0%) -(IGHD) -IGHJ3*02 (93.3%) T125>I (114), CDR-IMGT [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo sapiens IGHG1*01, G1m17,1 CH1 K120, CH3 D12, L14, 9-G1v21 CH2 Y15.1, T16, E18 (CH1 K120 (214) (118-215), hinge 1-15 (216-230), CH2 M15.1>Y (252), S16>T (254), T18>E (256) (231-340), CH3 D12 (356), L14 (358) (341-445), CHS (446-447)) (118-447)], (220-214')-disulfide with L-kappa light chain Homo sapiens (1'-214') [V-KAPPA (Homo sapiens IGKV3-11*01 (96.8%) -IGKJ4*01 (100%), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (CKAPPA A45.1 (153'), V101 (191')) (108'-214')]; dimer (226-226'':229-229'')-bisdisulfide, produced in a cell line derived from Chinese hamster ovary (CHO) cells, glycoform alfa
Breast Cancer
Kineta Inc.
P1/2
CC
(42)
xw003
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
P1/2
CC
(42)
Omnipaque
Breast Cancer
Alison Stopeck
P1
CC
(41)
[111in]-fpi-1967
Breast Cancer
Fusion Pharmaceuticals Inc.
P1/2
CC
(40)
[18f]f-resca-rb14
Breast Cancer
RenJi Hospital
P1/2
CC
(40)
[18f]f-resca-rt4
Breast Cancer
RenJi Hospital
P1/2
CC
(40)
[225Ac]-FPI-1966
Breast Cancer
Fusion Pharmaceuticals Inc.
P1/2
CC
(40)
4scar t cells
Breast Cancer
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(40)
Ace-86225106
Breast Cancer
Acerand Therapeutics (Shanghai) Limited
P1/2
CC
(40)
ak138d1
Breast Cancer
Akeso
P1/2
CC
(40)
AMXI-5001
Breast Cancer
AtlasMedx, Incorporated
P1/2
CC
(40)
Amxt1501
Breast Cancer
Aminex Therapeutics, Inc.
P1/2
CC
(40)
Anti-Hcd70 Car Transduced Pbl
Breast Cancer
National Cancer Institute (NCI)
P1/2
CC
(40)
Avutometinib
Breast Cancer
Adrienne G. Waks
P1/2
CC
(40)
Bacitracin
Breast Cancer
Jewish General Hospital
P1/2
CC
(40)
bc1 cell line
Breast Cancer
BriaCell Therapeutics Corporation
P1/2
CC
(40)
cl4
Breast Cancer
Fudan University
P1/2
CC
(40)
Dermaprazole 2%
Breast Cancer
Baylor College of Medicine
P1/2
CC
(40)
Dual-Target Antigen-Selected Car-Nk
Breast Cancer
Essen Biotech
P1/2
CC
(40)
Eb-Select Single-Target Car-Nk Cells
Breast Cancer
Essen Biotech
P1/2
CC
(40)
Eflornithine
Breast Cancer
Aminex Therapeutics, Inc.
P1/2
CC
(40)
Env-501
Breast Cancer
Hummingbird Bioscience
P1/2
CC
(40)
Epidiferphane
Breast Cancer
University of Florida
P1/2
CC
(40)
Showing 376 to 400 of 622 assets
Previous
Page 16 of 25
Next